Cover Page
Cover Page - shares | 6 Months Ended | |
Jun. 30, 2023 | Aug. 21, 2023 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Entity Registrant Name | 7GC & Co. Holdings Inc. | |
Current Fiscal Year End Date | --12-31 | |
Amendment Flag | false | |
Entity Central Index Key | 0001826011 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Jun. 30, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q2 | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Shell Company | true | |
Entity Ex Transition Period | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 001-39826 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 00-0000000 | |
Entity Address, Address Line One | 388 Market Street | |
Entity Address, Address Line Two | Suite 1300 | |
Entity Address, City or Town | San Francisco | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94111 | |
City Area Code | 628 | |
Local Phone Number | 400-9284 | |
Title of 12(b) Security | Shares of Class A Common Stock, par value $0.0001 per share | |
Trading Symbol | VII | |
Security Exchange Name | NASDAQ | |
Entity Interactive Data Current | Yes | |
Warrant [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock for $11.50 per share | |
Trading Symbol | VIIAW | |
Security Exchange Name | NASDAQ | |
Units [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant | |
Trading Symbol | VIIAU | |
Security Exchange Name | NASDAQ | |
Common Class A [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 3,329,638 | |
Common Class B [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 5,750,000 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
ASSETS | ||
Cash | $ 592,590 | $ 1,016,853 |
Prepaid expenses | 44,251 | 4,750 |
Total current assets | 636,841 | 1,021,603 |
Marketable securities held in Trust Account | 53,637,523 | 52,128,420 |
Total Assets | 54,274,364 | 53,150,023 |
Current liabilities: | ||
Accounts payable | 1,628,636 | 1,591,356 |
Due to related party | 67,118 | 47,694 |
Class A ordinary shares tendered for redemption, 1,747,139 shares at $10.55 to be paid out of Trust account | 18,432,316 | 0 |
Convertible loan from related party | 2,300,000 | 1,100,000 |
Income taxes payable | 482,504 | 765,554 |
Franchise tax payable | 100,000 | 80,050 |
Accrued expenses | 2,681,869 | 1,759,569 |
Total current liabilities | 25,692,443 | 5,344,223 |
Deferred underwriting fees payable | 8,050,000 | 8,050,000 |
Derivative warrant liabilities | 1,696,500 | 1,319,500 |
Total liabilities | 35,438,943 | 14,713,723 |
Commitments and Contingencies (Note 5) | ||
Class A common stock subject to possible redemption, $0.0001 par value; 3,329,638 and 5,076,777 shares at $10.57 and 10.23 per share at June 30, 2023 and December 31, 2022, respectively | 35,205,207 | 51,916,992 |
Stockholders' Deficit: | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | 0 | 0 |
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 3,329,638 and 5,076,777 shares issued or outstanding (excluding 3,329,638 and 5,076,777 shares subject to possible redemption as of June 30, 2023 and December 31, 2022, respectively) | 0 | 0 |
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and outstanding | 575 | 575 |
Additional paid-in capital | 0 | 0 |
Accumulated deficit | (16,370,361) | (13,481,267) |
Total stockholders' deficit | (16,369,786) | (13,480,692) |
Total Liabilities, Common Stock Subject to Possible Redemption, and Stockholders' Deficit | $ 54,274,364 | $ 53,150,023 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares | Jun. 30, 2023 | Dec. 31, 2022 |
Preferred stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common Class A [Member] | ||
Common stock, subject to possible redemption par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Temporary Equity, Shares Outstanding | 3,329,638 | 5,076,777 |
Temporary Equity, Redemption Price Per Share | $ 10.57 | $ 10.23 |
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 3,329,638 | 5,076,777 |
Common stock, shares outstanding | 3,329,638 | 5,076,777 |
Temporary equity share outstanding | 1,747,139 | |
Temporary equity per share | $ 10.55 | |
Common Class B [Member] | ||
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 10,000,000 | 10,000,000 |
Common stock, shares issued | 5,750,000 | 5,750,000 |
Common stock, shares outstanding | 5,750,000 | 5,750,000 |
Unaudited Condensed Consolidate
Unaudited Condensed Consolidated Statements Of Operations - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
General and administrative expenses | $ 890,936 | $ 233,847 | $ 1,483,692 | $ 573,479 |
Non-redemption agreement expense | 372,710 | 0 | 372,710 | 0 |
Franchise tax expenses | 50,000 | 64,906 | 100,000 | 114,271 |
Loss from operations | (1,313,646) | (298,753) | (1,956,402) | (687,750) |
Other income (expense) | ||||
Change in fair value of derivative warrant liabilities | 188,500 | 2,827,500 | (377,000) | 9,875,500 |
Gain on marketable securities (net), dividends and interest, held in Trust Account | 484,180 | 330,405 | 1,020,303 | 344,005 |
Other Income (expense) | 3,734 | 0 | 4,776 | 0 |
Income (loss) before taxes | (637,232) | 2,859,152 | (1,308,323) | 9,531,755 |
Income tax expense | 96,836 | 11,064 | 232,950 | 11,064 |
Net income (loss) | $ (734,068) | $ 2,848,088 | $ (1,541,273) | $ 9,520,691 |
Common Class A Subject To Possible Redemption [Member] | ||||
Other income (expense) | ||||
Weighted average shares outstanding, Basic | 4,999,980 | 23,000,000 | 5,038,166 | 23,000,000 |
Weighted average shares outstanding, Diluted | 4,999,980 | 23,000,000 | 5,038,166 | 23,000,000 |
Net income (loss) per share, Basic | $ (0.07) | $ 0.1 | $ (0.14) | $ 0.33 |
Net income (loss) per share, Diluted | $ (0.07) | $ 0.1 | $ (0.14) | $ 0.33 |
Common Class B Non Redeemable [Member] | ||||
Other income (expense) | ||||
Weighted average shares outstanding, Basic | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 |
Weighted average shares outstanding, Diluted | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 |
Net income (loss) per share, Basic | $ (0.07) | $ 0.1 | $ (0.14) | $ 0.33 |
Net income (loss) per share, Diluted | $ (0.07) | $ 0.1 | $ (0.14) | $ 0.33 |
Unaudited Condensed Consolida_2
Unaudited Condensed Consolidated Statements Of Changes In Stockholders' Deficit - USD ($) | Total | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Common Class B [Member] Common Stock [Member] |
Balance at Dec. 31, 2021 | $ (20,143,355) | $ 0 | $ (20,143,930) | $ 575 |
Balance (in Shares) at Dec. 31, 2021 | 5,750,000 | |||
Net income (loss) | 6,672,603 | 0 | 6,672,603 | |
Balance at Mar. 31, 2022 | (13,470,752) | 0 | (13,471,327) | $ 575 |
Balance (in Shares) at Mar. 31, 2022 | 5,750,000 | |||
Balance at Dec. 31, 2021 | (20,143,355) | 0 | (20,143,930) | $ 575 |
Balance (in Shares) at Dec. 31, 2021 | 5,750,000 | |||
Net income (loss) | 9,520,691 | |||
Balance at Jun. 30, 2022 | (10,622,664) | 0 | (10,623,239) | $ 575 |
Balance (in Shares) at Jun. 30, 2022 | 5,750,000 | |||
Balance at Mar. 31, 2022 | (13,470,752) | 0 | (13,471,327) | $ 575 |
Balance (in Shares) at Mar. 31, 2022 | 5,750,000 | |||
Net income (loss) | 2,848,088 | 0 | 2,848,088 | |
Balance at Jun. 30, 2022 | (10,622,664) | 0 | (10,623,239) | $ 575 |
Balance (in Shares) at Jun. 30, 2022 | 5,750,000 | |||
Balance at Dec. 31, 2022 | (13,480,692) | (13,481,267) | $ 575 | |
Balance (in Shares) at Dec. 31, 2022 | 5,750,000 | |||
Remeasurement of Class A common stock to redemption value | (350,009) | (350,009) | ||
Net income (loss) | (807,205) | (807,205) | $ 0 | |
Balance at Mar. 31, 2023 | (14,637,906) | (14,638,481) | $ 575 | |
Balance (in Shares) at Mar. 31, 2023 | 5,750,000 | |||
Balance at Dec. 31, 2022 | (13,480,692) | (13,481,267) | $ 575 | |
Balance (in Shares) at Dec. 31, 2022 | 5,750,000 | |||
Net income (loss) | (1,541,273) | |||
Balance at Jun. 30, 2023 | (16,369,786) | (16,370,361) | $ 575 | |
Balance (in Shares) at Jun. 30, 2023 | 5,750,000 | |||
Balance at Mar. 31, 2023 | (14,637,906) | (14,638,481) | $ 575 | |
Balance (in Shares) at Mar. 31, 2023 | 5,750,000 | |||
Remeasurement of Class A common stock to redemption value | (1,370,522) | (1,370,522) | ||
Net income (loss) | (734,068) | (734,068) | $ 0 | |
Contribution for non-redemption agreement | 372,710 | 372,710 | ||
Balance at Jun. 30, 2023 | $ (16,369,786) | $ (16,370,361) | $ 575 | |
Balance (in Shares) at Jun. 30, 2023 | 5,750,000 |
Unaudited Condensed Consolida_3
Unaudited Condensed Consolidated Statements Of Cash Flows - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2022 | Mar. 31, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Cash Flows from Operating Activities | |||||||
Net (loss) income | $ (734,068) | $ (807,205) | $ 2,848,088 | $ 6,672,603 | $ (1,541,273) | $ 9,520,691 | |
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |||||||
Non redemption agreement | 372,710 | 0 | |||||
Gain on marketable securities (net), dividends and interest, held in Trust Account | (484,180) | (330,405) | (1,020,303) | (344,005) | |||
Formation and operating expenses funded by note payable through Sponsor | 0 | 21,134 | |||||
Change in fair value of derivative warrant liabilities | (188,500) | (2,827,500) | 377,000 | (9,875,500) | |||
Changes in operating assets and liabilities: | |||||||
Prepaid and other assets | (20,077) | 95,499 | |||||
Income tax payable | (283,050) | 11,064 | |||||
Accounts payable | 37,280 | 7,242 | |||||
Accrued expenses | 942,250 | 158,377 | |||||
Net cash provided by (used in) operating activities | (1,135,463) | (405,498) | |||||
Cash Flows from Investing Activities | |||||||
Cash deposited in Trust Account for extension | (900,000) | 0 | |||||
Cash withdrawn from Trust Account to pay franchise and income taxes | 411,200 | 0 | |||||
Net cash used in investing activities | (488,800) | 0 | |||||
Cash Flows from Financing Activities: | |||||||
Offering costs paid | 0 | (70,000) | |||||
Proceeds from note payable and advances from related party | 1,200,000 | 0 | |||||
Net cash provided by (used in) financing activities | 1,200,000 | (70,000) | |||||
Net decrease in cash | (424,263) | (475,498) | |||||
Cash—beginning of period | $ 1,016,853 | $ 711,652 | 1,016,853 | 711,652 | $ 711,652 | ||
Cash—end of period | $ 592,590 | $ 236,154 | $ 592,590 | $ 236,154 | $ 1,016,853 |
Description of Organization and
Description of Organization and Business Operations | 6 Months Ended |
Jun. 30, 2023 | |
Description of Organization and Business Operations [Line Items] | |
Description of Organization and Business Operations | Note 1-Description Organization and General 7GC & Co. Holdings Inc. (the “Company”) was incorporated as a Delaware corporation on September 18, 2020. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of June 30, 2023, the Company has not commenced any operations. All activity for the period from September 18, 2020 (inception) through June 30, 2023, has been related to the Company’s formation and the initial public offering (“Initial Public Offering”) described below, and since the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenue until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating non-cash Sponsor and Financing The Company’s sponsor is 7GC & Co. Holdings LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on December 22, 2020. On December 28, 2020, the Company consummated its Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including 3,000,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.2 million, of which approximately $8.1 million was for deferred underwriting commissions (Note 5). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 7,350,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $7.4 million (Note 4). Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $230.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (the “Trust Account”) in the United States, with Continental Stock Transfer & Trust Company (“Continental”) acting as trustee, and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any money market funds meeting certain conditions of Rule 2a-7 of the Investment Company Act of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below. With respect to the regulation of SPACs like our company, on March 30, 2022, the SEC issued proposed rules relating to, among other items, the circumstances in which SPACs could become subject to regulation under the Investment Company Act. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, in December 2022 we instructed Continental, the trustee of the trust account, to liquidate the investments held in the trust account and instead to hold the funds in the trust account in an interest-bearing demand deposit account until the earlier of consummation of our initial business combination or liquidation. This may reduce the amount of interest earned by the funds in the trust account. As of June 30, 2023 and December 31, 2022, the funds in the trust account are held solely in an interest-bearing demand deposit account. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq Stock Market rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which public stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s amended and restated certificate of incorporation (the “Amended and Restated Certificate of Incorporation”) provides that, a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent. The Public Stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation with respect to the Company’s pre-Business pre-Business If the Company is unable to complete a Business Combination by June 28, 2023, or such earlier date as determined by the Company’s board of directors (the “Board” and such period, the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the Public Shares, at a per-share The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Proposed Business Combination On December 8, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the “Original Merger Agreement”) with Banzai International Inc., a Delaware corporation (“Banzai”), 7GC Merger Sub I, Inc., a Delaware corporation and an indirect wholly owned subsidiary of 7GC (“First Merger Sub”), and 7GC Merger Sub II, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of 7GC (“Second Merger Sub” and, together with First Merger Sub, the “Merger Subs” and each, a “Merger Sub”), as amended by the Amendment to Agreement and Plan of Merger, dated as of August 4, 2023, by and between 7GC and Banzai (the “Amendment” and together with the Original Merger Agreement, the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, the parties thereto will enter into a business combination transaction (the “Proposed Business Combination” and together with the other transactions contemplated by the Merger Agreement, the “Transactions”), pursuant to which, among other things, (i) First Merger Sub will merge with and into Banzai (the “First Merger”), with Banzai surviving as an indirect wholly owned subsidiary of the Company (the “Surviving Corporation”), and, (ii) immediately following the First Merger, the Surviving Corporation will merge with and into Second Merger Sub (the “Second Merger” and, together with the First Merger, the “Mergers”), with the Second Merger Sub surviving the Second Merger as a wholly owned subsidiary of 7GC. At the closing of the Transactions (the “Closing”), 7GC will change its name to Banzai International, Inc., and its common stock is expected to be listed on the Nasdaq Capital Market (“Nasdaq”). Pursuant to the Amendment, the Company and Banzai agreed to amend the terms and conditions of the Merger Agreement to provide (among other changes) that: (i) the closing of the Transactions is no longer conditioned upon the consummation of Banzai’s acquisition of Hyros Inc.; (ii) the value of the total consideration payable to Banzai stockholders is reduced from $293.0 million to $100.0 million, with no post-closing “earn-out” or other future contingent consideration; and (iii) the “Termination Date” upon which either party may terminate the Merger Agreement for any reason (subject to certain conditions set forth in the Merger Agreement) if the closing of the Transactions has not yet occurred is extended from September 8, 2023 to December 28, 2023. The aggregate consideration payable to Banzai security holders at the closing of the Transactions (the “Closing”) is $100.0 million, consisting of newly issued shares of the Company’s Class A common stock, par value $0.0001 per share (the “7GC New Class A Shares”), which will have one vote per share, and newly issued shares of the Company’s Class B common stock, par value $0.0001 per share (the “7GC New Class B Shares”), which will have ten votes per share, in each case, as such classes of common stock exist as of immediately following the First Effective Time, and cash in lieu of any fractional 7GC New Class A Shares or 7GC New Class B Shares that would otherwise be owed to any Pre-Closing The consummation of the Transactions is subject to customary closing conditions for transactions involving special purpose acquisition companies, including, among others: (i) approval of the 7GC Stockholder Matters (as defined in the Merger Agreement) by the Company’s stockholders, (ii) the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, (iii) no order, statute, rule or regulation enjoining or prohibiting the consummation of the Transactions being in force, (iv) the Registration Statement/Proxy Statement (as defined in the Merger Agreement) having become effective, (v) the 7GC New Class A Shares to be issued pursuant to the Merger Agreement having been approved for listing on Nasdaq, (vi) the Company having at least $ of net tangible assets remaining after redemptions by the Company’s stockholders, and (vii) customary bring-down conditions. Additionally, the obligations of Banzai and its subsidiaries to consummate the Transactions are also conditioned upon, among others, the satisfaction of a $5.0 million minimum net cash condition, being defined as an amount equal to the sum of (i) the cash proceeds to be received by the Company at Closing from the Trust Account established by the Company in connection with the Transactions (after, for the avoidance of doubt, giving effect to redemptions by the Company’s stockholders), (ii) the cash proceeds to be received by the Company or any of Banzai or its subsidiaries from any financing, whether equity or debt, at or immediately following the Closing, and (iii) the unrestricted cash on the balance sheet of Banzai as of immediately prior to the Closing, minus $ . The Company filed (i) a Current Report on Form 8-K with the SEC on December 8, 2022 including additional details, the Merger Agreement, and related supporting agreements, and (ii) a Current Report on Form 8-K with the SEC on August 7, 2023 including the Amendment and related supporting agreements . Stockholders Meeting, Trust Account Redemptions, Extension of Combination Period and Additional Trust Deposits On December 21, 2022, the Company held a special meeting of stockholders in lieu of an annual meeting of stockholders (the “Meeting”). At the Meeting, the Company’s stockholders approved an amendment to the Amended and Restated Certificate of Incorporation (the “Extension Amendment”) to extend the date by which the Company must consummate its initial Business Combination from December 28, 2022, within 24 months from the closing of the Initial Public Offering, to June 28, 2023, or such earlier date as determined by the Board (the “Extension”). Also on December 21, 2022, the Company filed the Extension Amendment with the Secretary of State of the State of Delaware. Stockholders holding 17,923,223 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Following redemptions, the Company has 5,076,777 Public Shares outstanding. After the satisfaction of such redemptions the balance of the Trust Account was approximately $52.1 million. In connection with the Extension, the Sponsor agreed to deposit into the Trust Account an aggregate of $900,000 plus $300,000 for each of the three subsequent calendar months commencing on March 29, 2023. As of June 30, 2023, $1,800,000 was deposited into the Trust Account for the benefit of the Public Stockholders. The Company issued an unsecured promissory note in connection with these fundings. See Note 4. On June 26, 2023, the Company held a special meeting of stockholders in lieu of an annual meeting of stockholders (the “Second Meeting”). At the Second Meeting, the Company’s stockholders approved an amendment to the Amended and Restated Certificate of Incorporation (the “Second Extension Amendment”) to extend the date by which the Company must consummate its initial Business Combination from June 28, 2023 to December 28, 2023, or such earlier date as determined by the Board (the “Second Extension”). Stockholders holding 1,747,139 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Following redemptions, the Company had Public Shares outstanding. After the satisfaction of such redemptions, which occurred after million . Prior to the Second Meeting, the Company and the Sponsor entered into non-redemption agreements (the “Non-Redemption Agreements”) with certain unaffiliated third parties (the “Holders”) in exchange for the Holders agreeing either not to request redemption, or to reverse any previously submitted redemption demand with respect to an aggregate of shares of Class A common stock, par value $ per share (the “Class A common stock”), of the Company sold in its Initial Public Offering, in connection with the Second Meeting to, among other things, approve the Second Extension Amendment to extend the date by which the Company must (i) consummate an initial business combination, (ii) cease all operations except for the purpose of winding up, and (iii) redeem or repurchase % of its Class A common stock included as part of the units sold in the IPO, from June 28, 2023 to December 28, 2023. In consideration of the foregoing agreements, immediately prior to, and substantially concurrently with, the closing of an initial Business Combination, (i) the Sponsor (or its designees) will surrender and forfeit to the Company for no consideration an aggregate of 396,500 shares of the Company’s Class B common stock, par value $0.0001 per share, held by the Sponsor (the “Forfeited Shares”) and (ii) the Company shall issue to the Holders a number of shares of Class A common stock equal to the number of Forfeited Shares. The Company estimated the aggregate fair value of the 396,500 Class B Ordinary Shares attributable to the Holders to be $372,710 or $0.94 per share. The excess of the fair value of the Class B Ordinary Shares was determined to be a cost associated with completing a Business Combination and a capital contribution from a related entity under SAB Topic 5T. Liquidity and Going Concern As of June 30, 2023, the Company had approximately $593,000 of cash in its operating account and a working capital deficit of approximately $4.3 million (excluding the convertible promissory note – related party and shares redeemed but not yet paid). During the period ended June 30, 2023 , Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account and loans from the Sponsor. Additionally, during the year ended December 31, 2022, approximately $1.1 million of the gain on investments held in the Trust Account was requested and released from the Trust Account in order to pay the Company’s tax obligations. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). On December 21, 2022, the Company issued an unsecured promissory note (the “Note”) to the Sponsor, which provides for borrowings from time to time of up to an aggregate of $2,300,000. Up to $500,000 of the Note may be drawn and used for working capital purposes (a “Working Capital Drawdown”) and up to $1,800,000 of the Note may be drawn and used to finance deposits to the Trust Account (an “Extension Drawdown”). As of June 30, 2023 there was $ The Company has incurred and expects to incur significant costs in pursuit of its Proposed Business Combination, which resulted in the Company’s accrued expenses being greater than the cash balance in its operating account. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) ASC Topic 205-40, “Presentation |
Basis of Presentation and Summa
Basis of Presentation and Summary of Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Summary of Significant Accounting Policies | Note 2-Basis Basis of Presentation The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2023, are not necessarily indicative of the results that may be expected through December 31, 2023 or any future period. The condensed consolidated financial statements include the accounts of 7GC & Co. Holdings Inc., its subsidiaries where we have controlling financial interests. All intercompany balances and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s unaudited condensed consolidated financial statements with those of another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the most significant accounting estimates included in these unaudited condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Actual results could differ from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit of $250,000, and any investments held in the Trust Account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. The Trust Account as of June 30, 2023 and December 31, 2022 was held in an interest-bearing demand deposit account. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company held no cash equivalents or cash equivalents outside the Trust Account as of June 30, 2023 and December 31, 2022. Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account prior to the extension period was comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on investments held in the Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. In December 2022 the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand deposit account until the earlier of consummation of a Business Combination and liquidation of the Company. As of June 30, 2023 and December 31, 2022, the funds in the Trust Account are held solely in an interest-bearing demand deposit account. Fair Value of Financial Instruments The carrying value of the Company’s assets and liabilities recognized in the condensed consolidated balance sheets, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the fair value for such assets and liabilities either because of the short-term nature of the instruments or because the instrument is recognized at fair value. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating non-current Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement non-current Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 3,329,638 and shares of Class A common stock, respectively , Under ASC 480-10-S99, paid-in paid-in Net Income (loss) Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a Business Combination as the most likely outcome. Net income (loss) per share of common stock is calculated by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the respective period. The calculation of diluted net income (loss) per common share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of shares of Class A common stock in the calculation of diluted income per common share, because their exercise is contingent upon future events. As a result, diluted net income (loss) (loss) per common share for the three and six months ended June 30, 2023 and 2022. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) For The Three Months Ended June, For The Six Months Ended June, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per Numerator: Allocation of net income $ (341,426 ) $ (392,642 ) $ 2,278,470 $ 569,618 $ (719,788 ) $ (821,485 ) $ 7,616,553 $ 1,904,138 Denominator: Basic and diluted weighted average 4,999,980 5,750,000 22,066,250 5,750,000 5,038,166 5,750,000 22,066,250 5,750,000 Basic and diluted net income (loss) $ (0.07 ) $ (0.07 ) $ 0.10 $ 0.10 $ (0.14 ) $ (0.14 ) $ 0.33 $ 0.33 Income Taxes The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of June 30, 2023 and December 31, 2022, deferred taxes were offset by their full valuation allowances. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements if currently adopted would have a material effect on the accompanying unaudited condensed consolidated financial statements. |
Initial Public Offering
Initial Public Offering | 6 Months Ended |
Jun. 30, 2023 | |
Initial Public Offering [Abstract] | |
Initial Public Offering | Note 3-Initial On December 28, 2020, the Company consummated its Initial Public Offering of 23,000,000 Units, including 3,000,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $13.2 million, of which approximately $8.1 million was for deferred underwriting commissions. Each Unit consists of one share of Class A common stock, and one-half |
Related Party Transactions
Related Party Transactions | 6 Months Ended |
Jun. 30, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 4-Related Founder Shares On September 18, 2020, the Sponsor purchased 5,031,250 shares of the Company’s Class B common stock, par value $0.0001 per share, (the “Founder Shares”) for an aggregate purchase price of $25,000, or approximately $0.005 per share. On December 1, 2020, the Sponsor transferred 25,000 Founder Shares to each of the Company’s four director nominees. In December 2020, the Company effected a stock dividend of approximately 0.143 shares for each share of Class B common stock outstanding, resulting in an aggregate of 5,750,000 Founder Shares outstanding. Certain of the initial stockholders then retransferred an aggregate of 14,286 shares back to the Sponsor. Of the 5,750,000 Founder Shares outstanding, up to 750,000 shares were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full, so that the initial stockholders would own 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. The underwriters exercised their over-allotment option in full on December 28, 2020; thus, the 750,000 Founder Shares were no longer subject to forfeiture. The Company’s initial stockholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Prior to the Second Meeting, the Company and the Sponsor entered into Non-Redemption Agreements with the Holders in exchange for the Holders agreeing either not to request redemption, or to reverse any previously submitted redemption demand with respect to an aggregate of 3,172,000 shares of Class A Common Stock of the Company sold in its Initial Public Offering, in connection with the Second Meeting to, among other things, approve the Second Extension Amendment to extend the date by which the Company must (i) consummate an initial business combination, (ii) cease all operations except for the purpose of winding up, and (iii) redeem or repurchase 100% of its Class A common stock included as part of the units sold in the IPO, from June 28, 2023 to December 28, 2023. In consideration of the foregoing agreements, immediately prior to, and substantially concurrently with, the closing of an initial Business Combination, (i) the Sponsor (or its designees) will surrender and forfeit to the Company for no consideration the Forfeited Shares and (ii) the Company shall issue to the Holders a number of shares of Class A common stock equal to the number of Forfeited Shares. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 7,350,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $7.4 million. Each warrant is exercisable to purchase one share of the Company’s Class A common stock at a price of $11.50 per share. Certain proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirement of applicable law) and the Private Placement Warrants will expire worthless. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders’ discretion, up to $1.5 million of notes may be converted upon consummation of a Business Combination into additional Private Placement Warrants at a price of $1.00 per Warrant. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of June 30, 2023 and December 31, 2022, the Company had nothing outstanding under this Working Capital Loan. On December 21, 2022, the Company issued the Note to the Sponsor, which provides for borrowings from time to time of up to an aggregate of $2,300,000. Up to $500,000 of the Note may be drawn and used for Working Capital Drawdowns and up to $1,800,000 of the Note may be drawn and used for Extension Drawdowns. The Company borrowed $1,100,000 under the Note on December 21, 2022, $900,000 of which was an Extension Drawdown and $200,000 of which was a Working Capital Drawdown. The Note does not bear interest and is repayable in full upon the earlier of the consummation of a Business Combination or the date the Company liquidates the Trust Account upon the failure of the Company to consummate a Business Combination within the requisite time period. Upon the consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the principal balance of the Note, in whole or in part, into that number of shares of Class A common stock, $0.0001 par value per share, of the Company (the “Converted Shares”) equal to the principal amount of the Note so converted divided by $10.00. The terms of the Converted Shares, if issued, will be identical to the terms of the Company’s Public Shares, except that the Converted Shares (x) will not be registered under the Securities Act, and (y) will be subject to the terms of that certain letter agreement, dated as of December 22, 2020, among the Company, the Sponsor, and certain other parties thereto. The Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable. On February 9, 2023 the Company borrowed an additional $177,500 under the Note which was a Working Capital Drawdown . 122,500 500,000 During the three months ended June 30, . Administrative Support Agreement The Company agreed to pay $10,000 a month for office space, utilities, and secretarial and administrative support to the Sponsor. Services commenced on the date the securities were first listed on Nasdaq and will terminate upon the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company. In the three and six months ended June 30, 2023 and 2022, the Company incurred approximately $30,000 and $ Due to Related Party In the three and six months ended June 30, 2023, the Sponsor paid certain expenses on behalf of the Company, there were no such expenses in the three and six months ended June 30, 2022. As of June 30, 2023, the outstanding balance for such advances were approximately $ |
Commitments & Contingencies
Commitments & Contingencies | 6 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments & Contingencies | Note 5-Commitments & Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) were entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were entitled to a cash underwriting discount of 2.0% of the gross proceeds of the Initial Public Offering, or $4.6 million in the aggregate. In addition, the representative of the underwriters is entitled to a deferred fee of 3.5% of the gross proceeds of the Initial Public Offering, or approximately $8.1 million. The deferred fee will become payable to the representative of the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Non-redemption Agreement Prior to the Second Meeting, the Company and the Sponsor entered into non-redemption agreements (the “Non-Redemption Agreements”) with certain unaffiliated third parties (the “Holders”) in exchange for the Holders agreeing either not to request redemption, or to reverse any previously submitted redemption demand with respect to an aggregate of 3,172,000 shares of Class A common stock, par value $0.0001 per share (the “Class A common stock”), of the Company sold in its Initial Public Offering, in connection with the Second Meeting to, among other things, approve the Second Extension Amendment to extend the date by which the Company must (i) consummate an initial business combination, (ii) cease all operations except for the purpose of winding up, and (iii) redeem or repurchase 100% of its Class A common stock included as part of the units sold in the IPO, from June 28, 2023 to December 28, 2023. In consideration of the foregoing agreements, immediately prior to, and substantially concurrently with, the closing of an initial Business Combination, (i) the Sponsor (or its designees) will surrender and forfeit to the Company for no consideration an aggregate of 396,500 shares of the Company’s Class B common stock, par value $0.0001 per share, held by the Sponsor (the “Forfeited Shares”) and (ii) the Company shall issue to the Holders a number of shares of Class A common stock equal to the number of Forfeited Shares. The Company estimated the aggregate fair value of the 396,500 Class B Ordinary Shares attributable to the Holders to be $372,710 or $0.94 per share. The excess of the fair value of the Class B Ordinary Shares was determined to be a cost associated with completing a Business Combination and a capital contribution from a related entity under SAB Topic 5T. Risks and Uncertainties Various social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. Specifically, the continuing conflict between Russia and Ukraine, and resulting market volatility could adversely affect the Company’s ability to complete a business combination. In response to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a business combination and the value of the Company’s securities. Management continues to evaluate the impact of these types of risks and has concluded that while it is reasonably possible that these risks and uncertainties could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. In order to mitigate the current uncertainty surrounding the implementation of the IR Act, the Sponsor, or a designee, agreed to indemnify the Company for any excise tax liabilities with respect to any future redemptions that occur after December 31, 2022 and prior to or in connection with a Business Combination or liquidation of the Company. The foregoing would mitigate a potential reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. |
Derivative Warrant Liabilities
Derivative Warrant Liabilities | 6 Months Ended |
Jun. 30, 2023 | |
Derivative Warrant Liabilities [Line Items] | |
Derivative Warrant Liabilities | Note 6-Derivative As of June 30, 2023 and December 31, 2022, the Company had 11,500,000 Public Warrants and 7,350,000 Private Placement Warrants outstanding. The Public Warrants will become exercisable on the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the closing of the Initial Public Offering, provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, it will its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, the warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except for the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per Warrant; • upon a minimum of 30 days’ prior written notice of redemption (the “30-day • if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading The Company will not redeem the warrants unless a registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants, and the shares of common stock issuable upon the exercise of the Private Placement Warrants will not, be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable |
Class A Common Stock Subject to
Class A Common Stock Subject to Possible Redemption | 6 Months Ended |
Jun. 30, 2023 | |
Class A Common Stock Subject to Possible Redemption [Abstract] | |
Class A Common Stock Subject to Possible Redemption | Note 7-Class The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of June 30, 2023 and December 31, 2022, there were 3,329,638 and 5,076,777 shares of Class A common stock outstanding, respectively, which were all subject to possible redemption and are classified outside of permanent equity in the condensed consolidated balance sheets. On December 2, 2022 and June 26, 2023, the Company held the stockholders meetings described in Note 1. Stockholders holding 17,923,223 and 1,747,139 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. In addition, as of June 30, 2023 and December 31, 2022, $1,800,000 was deposited by the Company in to the Trust Account for the benefit of the public stockholders. As of June 30, 2023, 1,747,139 Class A ordinary shares have been tendered for redemption. These shares were deemed to be mandatorily redeemable as of June 30, 2023 and were classified as liabilities at approximately $10.55 per share. The Class A common stock subject to possible redemption reflec te alan Gross proceeds $ 230,000,000 Less: Class A common stock issuance costs (12,403,774 ) Fair value of Public Warrants at issuance (13,340,000 ) Fair value of rights — Plus: Remeasurement of Class A common stock to redemption value 28,519,292 Redemption of Class A common stock (180,858,526 ) Class A common stock subject to possible redemption at December 31, 2022 $ 51,916,992 Remeasurement of Class A common stock to redemption value 1,720,531 Class A ordinary shares tendered for redemption (18,432,316 ) Class A common stock subject to possible redemption at June 30, 2023 $ 35,205,207 |
Stockholders' Deficit
Stockholders' Deficit | 6 Months Ended |
Jun. 30, 2023 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Deficit | Note 8-Stockholders’ Preferred stock no Class A common stock Class B common stock Holders of the Company’s Class B common stock are entitled to one vote for each share. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one as-converted |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 9-Fair The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. June 30, 2023 Description Quoted Significant Significant Liabilities: Derivative warrant liabilities – Public $ — $ 1,035,000 $ — Derivative warrant liabilities – Private Placement $ — $ 661,500 $ — December 31, 2022 Description Quoted Significant Significant Liabilities: Derivative warrant liabilities – Public $ 805,000 $ — $ — Derivative warrant liabilities – Private Placement $ — $ 514,500 $ — There were no assets that were required to be measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022. Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement, as the Public Warrants were separately listed and traded in February 2021. The estimated fair value of the Private Placement Warrants was transferred from a Level 3 fair value measurement to a Level 2 fair value measurement in the fourth quarter of 2022. As the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant due to the low probability of the redemption feature only applicable to the Public Warrants being triggered. The Public Warrants were transferred to Level 2 in the first quarter of 2023 due to the low trading volume of the security. The fair values of the Public Warrants and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair values of the Private Placement Warrants have continued to be measured using a similar simulation model through June 30, 2023. The fair values of Public Warrants have been measured based on the listed market price of such warrants, until December 31, 2022 until trading volume decreased and the public warrants were valued in a similar manner as the private warrants. In the periods ended June 30, 2023 and December 31, 2022, the Company recognized a benefit (loss) of approximately ($0.4) million and $10.3 million, respectively, resulting from changes in the fair value of the derivative warrant liabilities, presented as change in fair value of derivative warrant liabilities in the accompanying condensed The estimated fair values of the Private Placement Warrants and the Public Warrants prior to being separately listed and traded, were initially determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon The changes in the fair value of the Level 3 derivative warrant liabilities for the six June 30 2022 Derivative warrant liabilities at January 1, $ 4,557,000 Change in fair value of derivative warrant liabilities (2,793,000 ) Transfer of Public Warrants to Level 1 — Derivative warrant liabilities at March 31, 1,764,000 Change in fair value of derivative warrant liabilities (1,102,500 ) Derivative warrant liabilities at June 30, $ 661,500 |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 10-Subsequent The Company evaluated subsequent events and transactions that occurred after the condensed consolidated balance sheet s In July 2023, $18,432,316 was paid to s o |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2023, are not necessarily indicative of the results that may be expected through December 31, 2023 or any future period. The condensed consolidated financial statements include the accounts of 7GC & Co. Holdings Inc., its subsidiaries where we have controlling financial interests. All intercompany balances and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s unaudited condensed consolidated financial statements with those of another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the most significant accounting estimates included in these unaudited condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Actual results could differ from those estimates. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit of $250,000, and any investments held in the Trust Account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. The Trust Account as of June 30, 2023 and December 31, 2022 was held in an interest-bearing demand deposit account. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company held no cash equivalents or cash equivalents outside the Trust Account as of June 30, 2023 and December 31, 2022. |
Investments Held in the Trust Account | Investments Held in the Trust Account The Company’s portfolio of investments held in the Trust Account prior to the extension period was comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on investments held in the Trust Account in the accompanying unaudited condensed consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. In December 2022 the Company instructed the trustee of the Trust Account to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand deposit account until the earlier of consummation of a Business Combination and liquidation of the Company. As of June 30, 2023 and December 31, 2022, the funds in the Trust Account are held solely in an interest-bearing demand deposit account. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The carrying value of the Company’s assets and liabilities recognized in the condensed consolidated balance sheets, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the fair value for such assets and liabilities either because of the short-term nature of the instruments or because the instrument is recognized at fair value. |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
Offering Costs | Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating non-current |
Derivative Warrant Liabilities | Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement non-current |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 3,329,638 and shares of Class A common stock, respectively , Under ASC 480-10-S99, paid-in paid-in |
Net Income (loss) Per Share of Common Stock | Net Income (loss) Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a Business Combination as the most likely outcome. Net income (loss) per share of common stock is calculated by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the respective period. The calculation of diluted net income (loss) per common share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of shares of Class A common stock in the calculation of diluted income per common share, because their exercise is contingent upon future events. As a result, diluted net income (loss) (loss) per common share for the three and six months ended June 30, 2023 and 2022. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) For The Three Months Ended June, For The Six Months Ended June, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per Numerator: Allocation of net income $ (341,426 ) $ (392,642 ) $ 2,278,470 $ 569,618 $ (719,788 ) $ (821,485 ) $ 7,616,553 $ 1,904,138 Denominator: Basic and diluted weighted average 4,999,980 5,750,000 22,066,250 5,750,000 5,038,166 5,750,000 22,066,250 5,750,000 Basic and diluted net income (loss) $ (0.07 ) $ (0.07 ) $ 0.10 $ 0.10 $ (0.14 ) $ (0.14 ) $ 0.33 $ 0.33 |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of June 30, 2023 and December 31, 2022, deferred taxes were offset by their full valuation allowances. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements if currently adopted would have a material effect on the accompanying unaudited condensed consolidated financial statements. |
Basis of Presentation and Sum_2
Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Schedule of basic and diluted net income per share | The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) For The Three Months Ended June, For The Six Months Ended June, 2023 2022 2023 2022 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per Numerator: Allocation of net income $ (341,426 ) $ (392,642 ) $ 2,278,470 $ 569,618 $ (719,788 ) $ (821,485 ) $ 7,616,553 $ 1,904,138 Denominator: Basic and diluted weighted average 4,999,980 5,750,000 22,066,250 5,750,000 5,038,166 5,750,000 22,066,250 5,750,000 Basic and diluted net income (loss) $ (0.07 ) $ (0.07 ) $ 0.10 $ 0.10 $ (0.14 ) $ (0.14 ) $ 0.33 $ 0.33 |
Class A Common Stock Subject _2
Class A Common Stock Subject to Possible Redemption (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Class A Common Stock Subject to Possible Redemption [Abstract] | |
Schedule of class A common stock subject to possible redemption | The Class A common stock subject to possible redemption reflec te alan Gross proceeds $ 230,000,000 Less: Class A common stock issuance costs (12,403,774 ) Fair value of Public Warrants at issuance (13,340,000 ) Fair value of rights — Plus: Remeasurement of Class A common stock to redemption value 28,519,292 Redemption of Class A common stock (180,858,526 ) Class A common stock subject to possible redemption at December 31, 2022 $ 51,916,992 Remeasurement of Class A common stock to redemption value 1,720,531 Class A ordinary shares tendered for redemption (18,432,316 ) Class A common stock subject to possible redemption at June 30, 2023 $ 35,205,207 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of fair value on a recurring basis | June 30, 2023 Description Quoted Significant Significant Liabilities: Derivative warrant liabilities – Public $ — $ 1,035,000 $ — Derivative warrant liabilities – Private Placement $ — $ 661,500 $ — December 31, 2022 Description Quoted Significant Significant Liabilities: Derivative warrant liabilities – Public $ 805,000 $ — $ — Derivative warrant liabilities – Private Placement $ — $ 514,500 $ — |
Schedule of derivative warrant liabilities | 2022 Derivative warrant liabilities at January 1, $ 4,557,000 Change in fair value of derivative warrant liabilities (2,793,000 ) Transfer of Public Warrants to Level 1 — Derivative warrant liabilities at March 31, 1,764,000 Change in fair value of derivative warrant liabilities (1,102,500 ) Derivative warrant liabilities at June 30, $ 661,500 |
Description of Organization a_2
Description of Organization and Business Operations (Details) - USD ($) | 6 Months Ended | ||||||||
Jun. 26, 2023 | Jun. 16, 2023 | Dec. 08, 2022 | Dec. 02, 2022 | Dec. 28, 2020 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Dec. 21, 2022 | |
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Fair market value percentage | 80% | ||||||||
Percentage of outstanding voting securities | 50% | ||||||||
Net tangible assets | $ 5,000,001 | ||||||||
Public shares percentage | 15% | ||||||||
Dissolution expenses | $ 100,000 | ||||||||
Offering price per (in Dollars per share) | $ 10 | ||||||||
Trust account, description | The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). | ||||||||
Operating cash account | $ 593,000 | ||||||||
Working capital | $ 4,300,000 | ||||||||
Common stock voting rights | ten votes | ||||||||
Cash and cash equivalents, at carrying value | $ 592,590 | $ 1,016,853 | |||||||
Assets held in trust noncurrent | 53,637,523 | 52,128,420 | |||||||
Cash withdrawn from trust account to pay tax obligations | 1,100,000 | ||||||||
Unrealized gain (loss) on investments | 1,100,000 | ||||||||
Proceeds from Sale of Restricted Investments | 411,000 | ||||||||
Sponsor [Member] | Unsecured Promissory Note [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Maximum borrowing capacity | $ 500,000 | ||||||||
Notes payable | 500,000 | 200,000 | |||||||
Sponsor [Member] | Working Capital Drawdowns [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Maximum borrowing capacity | 500,000 | 900,000 | |||||||
Additional borrowing capacity | $ 300,000 | ||||||||
Notes payable | 1,800,000 | ||||||||
Sponsor [Member] | Extension Drawdowns [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Maximum borrowing capacity | 1,800,000 | 1,800,000 | |||||||
Notes payable | $ 1,800,000 | $ 900,000 | |||||||
Sponsor [Member] | Working Capital Drawdowns and Extension Drawdowns [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Common stock, par value | $ / shares | $ 0.0001 | ||||||||
Maximum borrowing capacity | $ 2,300,000 | $ 2,300,000 | |||||||
Common Class A [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Common stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | |||||||
Temperory equity shares during the period shares | 1,747,139 | 17,923,223 | 17,923,223 | ||||||
Temporary equity common stock possible to redemption shares | 3,329,638 | 5,076,777 | 3,329,638 | 5,076,777 | |||||
Assets held in trust noncurrent | $ 36,900,000 | $ 52,100,000 | |||||||
Temporary equity, shares outstanding | 3,329,638 | 5,076,777 | |||||||
Percentage of redemption of common stock subject to forfeiture | 100% | ||||||||
Common stock, subject to possible redemption par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |||||||
Common Class A [Member] | Holder [Member] | Non Redemption Agreement [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Temporary equity, shares outstanding | 3,172,000 | ||||||||
Common stock, subject to possible redemption par value (in Dollars per share) | $ 0.0001 | ||||||||
Common Class B [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Common stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | |||||||
Common Class B [Member] | Holder [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Number of shares issued during the period | $ 396,500 | ||||||||
Fair value of common stock issued | $ 372,710 | ||||||||
Stock fair value | 0.94% | ||||||||
Common Class B [Member] | Sponsor [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Common stock, par value | $ / shares | $ 0.0001 | ||||||||
Stock forfeited and surrendered during the period value | $ 0 | ||||||||
Stock forfeited and surrendered during the period Shares | 396,500 | ||||||||
Banzai International Inc [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Net tangible assets | 5,000,001 | ||||||||
Pro forma enterprise value reduction | 100,000,000 | ||||||||
Common stock voting rights | one vote | ||||||||
Cash and cash equivalents, at carrying value | 5,000,000 | ||||||||
Minimum Amount Net Cash Condition For Business Combination | $ 5,000,000 | ||||||||
Banzai International Inc [Member] | 7GC New Class A Shares [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Common stock, par value | $ / shares | $ 0.0001 | ||||||||
Banzai International Inc [Member] | 7GC New Class B Shares [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Common stock, par value | $ / shares | $ 0.0001 | ||||||||
IPO [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Number of units issued in transaction (in Shares) | 23,000,000 | ||||||||
Per unit price (in Dollars per share) | $ 10 | ||||||||
Generating gross proceeds | $ 230,000,000 | ||||||||
Offering costs | 13,200,000 | ||||||||
Deferred underwriting commissions | $ 8,100,000 | ||||||||
Redemption percentage of public shares (in Dollars per share) | $ 10 | ||||||||
Over-Allotment Option [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Number of units issued in transaction (in Shares) | 3,000,000 | ||||||||
Private Placement Warrant [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Number of units issued in transaction (in Shares) | 7,350,000 | ||||||||
Per unit price (in Dollars per share) | $ 1 | ||||||||
Generating gross proceeds | $ 7,400,000 | ||||||||
Minimum [Member] | Banzai International Inc [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Pro forma enterprise value reduction | $ 293,000,000 | ||||||||
Maximum [Member] | Banzai International Inc [Member] | |||||||||
Description of Organization and Business Operations (Details) [Line Items] | |||||||||
Pro forma enterprise value reduction | $ 100,000,000 |
Basis of Presentation and Sum_3
Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2023 | Dec. 31, 2022 | |
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items] | ||
Federal depository insurance coverage (in Dollars) | $ 250,000 | |
Private Placement [Member] | ||
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items] | ||
Sale of Stock, Number of Shares Issued in Transaction | 18,850,000 | |
Common Class A [Member] | ||
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items] | ||
Subject to possible redemption | 3,329,638 | 5,076,777 |
Basis of Presentation and Sum_4
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Common Class A [Member] | ||||
Numerator: | ||||
Allocation of net income (loss) | $ (341,426) | $ 2,278,470 | $ (719,788) | $ 7,616,553 |
Denominator: | ||||
Weighted average shares outstanding, Basic | 4,999,980 | 22,066,250 | 5,038,166 | 22,066,250 |
Weighted average shares outstanding, Diluted | 4,999,980 | 22,066,250 | 5,038,166 | 22,066,250 |
Net income (loss) per share, Basic | $ (0.07) | $ 0.1 | $ (0.14) | $ 0.33 |
Net income (loss) per share, Diluted | $ (0.07) | $ 0.1 | $ (0.14) | $ 0.33 |
Common Class B [Member] | ||||
Numerator: | ||||
Allocation of net income (loss) | $ (392,642) | $ 569,618 | $ (821,485) | $ 1,904,138 |
Denominator: | ||||
Weighted average shares outstanding, Basic | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 |
Weighted average shares outstanding, Diluted | 5,750,000 | 5,750,000 | 5,750,000 | 5,750,000 |
Net income (loss) per share, Basic | $ (0.07) | $ 0.1 | $ (0.14) | $ 0.33 |
Net income (loss) per share, Diluted | $ (0.07) | $ 0.1 | $ (0.14) | $ 0.33 |
Initial Public Offering (Detail
Initial Public Offering (Details) - USD ($) $ / shares in Units, $ in Millions | 6 Months Ended | |
Dec. 28, 2020 | Jun. 30, 2023 | |
Initial Public Offering (Details) [Line Items] | ||
Description of initial public offering | Each Unit consists of one share of Class A common stock, and one-half of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). | |
IPO [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Number of units issued in transaction (in Shares) | 23,000,000 | |
Price per share (in Dollars per share) | $ 10 | |
Gross proceeds from initial public offering | $ 230 | |
Offering costs | 13.2 | |
Deferred underwriting commission | $ 8.1 | |
Over-Allotment Option [Member] | ||
Initial Public Offering (Details) [Line Items] | ||
Number of units issued in transaction (in Shares) | 3,000,000 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||
Feb. 09, 2023 | Dec. 28, 2020 | Dec. 31, 2020 | Sep. 18, 2020 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | Jun. 16, 2023 | Dec. 21, 2022 | |
Related Party Transactions (Details) [Line Items] | |||||||||||
Office space, utilities and secretarial and administrative support expenses | $ 10,000 | ||||||||||
Incurred and expensed expenses | $ 30,000 | $ 60,000 | 30,000 | $ 60,000 | |||||||
Outstanding balance for advances | $ 67,118 | 67,118 | $ 47,694 | ||||||||
Proceeds from related party debt | $ 1,200,000 | $ 0 | |||||||||
Debt instrument conversion price per share | $ / shares | $ 10 | $ 10 | |||||||||
Loans payable current | $ 2,300,000 | $ 2,300,000 | $ 1,100,000 | ||||||||
Over-Allotment Option [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Purchase of shares | 3,000,000 | ||||||||||
Private Placement [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Purchase of shares | 18,850,000 | ||||||||||
Warrants issued | 7,350,000 | ||||||||||
Warrants price per share | $ 1 | $ 1 | |||||||||
Generating gross proceeds | $ 7,400,000 | ||||||||||
Founder Shares [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Purchase of shares | $ 25,000 | ||||||||||
Price per share | $ 0.005 | ||||||||||
Transfer of shares | 25,000 | ||||||||||
Founder shares outstanding | 5,750,000 | ||||||||||
Transfer of initial stockholders share | 14,286 | ||||||||||
Shares subject to forfeiture | 750,000 | ||||||||||
Issued and outstanding shares percentage | 20% | ||||||||||
Founder Shares [Member] | Over-Allotment Option [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Shares subject to forfeiture | 750,000 | ||||||||||
Common Class B [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Common stock par value | 0.0001 | $ 0.0001 | $ 0.0001 | ||||||||
Common Class B [Member] | Founder Shares [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Purchase of shares | 5,031,250 | ||||||||||
Common stock par value | $ 0.0001 | ||||||||||
Stock dividends | 0.143 | ||||||||||
Founder shares outstanding | 5,750,000 | ||||||||||
Common Class A [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Common stock par value | 0.0001 | 0.0001 | $ 0.0001 | ||||||||
Common stock equals or exceeds per share | $ 12 | $ 12 | |||||||||
Temporary equity, shares outstanding | 3,329,638 | 3,329,638 | 5,076,777 | ||||||||
Percentage of redemption of common stock subject to forfeiture | 100% | ||||||||||
Common Class A [Member] | Non Redemption Agreement [Member] | Holder [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Temporary equity, shares outstanding | 3,172,000 | ||||||||||
Common Class A [Member] | Private Placement [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Warrants price per share | $ 11.5 | $ 11.5 | |||||||||
Sponsor [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Outstanding balance for advances | $ 67,000 | $ 67,000 | |||||||||
Due to Related Parties | $ 10,000 | $ 10,000 | $ 0 | ||||||||
Sponsor [Member] | Working Capital Drawdowns and Extension Drawdowns [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Common stock par value | $ 0.0001 | $ 0.0001 | |||||||||
Maximum borrowing capacity | $ 2,300,000 | $ 2,300,000 | $ 2,300,000 | ||||||||
Proceeds from related party debt | 1,100,000 | ||||||||||
Sponsor [Member] | Working Capital Drawdowns [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Maximum borrowing capacity | 500,000 | 500,000 | 900,000 | ||||||||
Proceeds from related party debt | $ 177,500 | 122,500 | 900,000 | ||||||||
Debt Instrument Carrying Amount | 500,000 | 500,000 | |||||||||
Sponsor [Member] | Extension Drawdowns [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Maximum borrowing capacity | 1,800,000 | 1,800,000 | $ 1,800,000 | ||||||||
Proceeds from related party debt | 900,000 | 200,000 | |||||||||
Debt Instrument Carrying Amount | $ 1,800,000 | $ 1,800,000 | |||||||||
Sponsor [Member] | Out Of Pocket Expenses [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Outstanding balance for advances | $ 48,000 | ||||||||||
Sponsor [Member] | Common Class B [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Common stock par value | $ 0.0001 | ||||||||||
Working Capital Loans [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Warrants price per share | $ 1 | $ 1 | |||||||||
Related party transaction | $ 1,500,000 |
Commitments & Contingencies (De
Commitments & Contingencies (Details) - USD ($) | 1 Months Ended | 6 Months Ended | ||
Jun. 16, 2023 | Aug. 16, 2022 | Jun. 30, 2023 | Dec. 31, 2022 | |
Loss Contingencies [Line Items] | ||||
Underwriting discount percentage | 2% | |||
Underwriting expense (in Dollars) | $ 4,600,000 | |||
Underwriters deferred fee percentage | 3.50% | |||
Gross proceeds (in Dollars) | $ 8,100,000 | |||
U.S.federal excise tax, percentage | 1% | |||
Fair market value, percentage | 1% | |||
Class A Common Stock [Member] | ||||
Loss Contingencies [Line Items] | ||||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 | ||
Temporary equity, shares outstanding | 3,329,638 | 5,076,777 | ||
Common stock, subject to possible redemption par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | ||
Percentage of redemption of common stock subject to forfeiture | 100% | |||
Class A Common Stock [Member] | Holder [Member] | Non Redemption Agreement [Member] | ||||
Loss Contingencies [Line Items] | ||||
Temporary equity, shares outstanding | 3,172,000 | |||
Common stock, subject to possible redemption par value (in Dollars per share) | $ 0.0001 | |||
Class B Common Stock [Member] | ||||
Loss Contingencies [Line Items] | ||||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 | ||
Class B Common Stock [Member] | Holder [Member] | ||||
Loss Contingencies [Line Items] | ||||
Number of shares issued during the period | $ 396,500 | |||
Stock fair value | 0.94% | |||
Fair value of common stock issued | $ 372,710 | |||
Class B Common Stock [Member] | Sponsor Member | ||||
Loss Contingencies [Line Items] | ||||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | |||
Stock forfeited and surrendered during the period value | $ 0 | |||
Stock forfeited and surrendered during the period Shares | 396,500 |
Derivative Warrant Liabilities
Derivative Warrant Liabilities (Details) - shares | 6 Months Ended | |
Jun. 30, 2023 | Dec. 31, 2022 | |
Derivative Warrant Liabilities (Details) [Line Items] | ||
Warrants exercise price, description | The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. | |
Warrants become exercisable, description | Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except for the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per Warrant; • upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and • if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the Warrants become exercisable and ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. | |
Public Warrants [Member] | ||
Derivative Warrant Liabilities (Details) [Line Items] | ||
Warrants outstanding | 11,500,000 | 11,500,000 |
Private Placement Warrants [Member] | ||
Derivative Warrant Liabilities (Details) [Line Items] | ||
Warrants outstanding | 7,350,000 | 7,350,000 |
Class A Common Stock Subject _3
Class A Common Stock Subject to Possible Redemption (Details) - USD ($) | Jun. 26, 2023 | Dec. 08, 2022 | Dec. 02, 2022 | Jun. 30, 2023 | Dec. 31, 2022 |
Related Party [Member] | |||||
Class A Common Stock Subject to Possible Redemption (Details) [Line Items] | |||||
Notes payable | $ 1,800,000 | $ 1,800,000 | |||
Common Class A [Member] | |||||
Class A Common Stock Subject to Possible Redemption (Details) [Line Items] | |||||
Common stock, shares authorized | 100,000,000 | 100,000,000 | |||
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |||
Common stock, subject to possible redemption, shares | 3,329,638 | 5,076,777 | 3,329,638 | 5,076,777 | |
Temperory equity shares during the period shares | 1,747,139 | 17,923,223 | 17,923,223 | ||
Temporary equity per share | $ 10.55 | ||||
Temporary equity share outstanding | 1,747,139 |
Class A Common Stock Subject _4
Class A Common Stock Subject to Possible Redemption (Details) - Schedule of class A common stock subject to possible redemption - Common Class A [Member] - USD ($) | 6 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Dec. 31, 2022 | |
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items] | ||
Gross proceeds | $ 230,000,000 | |
Less: | ||
Class A common stock issuance costs | (12,403,774) | |
Fair value of Public Warrants at issuance | (13,340,000) | |
Fair value of rights | 0 | |
Plus: | ||
Remeasurement of Class A common stock to redemption value | $ 1,720,531 | 28,519,292 |
Redemption of Class A common stock | (18,432,316) | (180,858,526) |
Class A common stock subject to possible redemption | $ 35,205,207 | $ 51,916,992 |
Stockholders' Deficit (Details)
Stockholders' Deficit (Details) - $ / shares | 6 Months Ended | |
Jun. 30, 2023 | Dec. 31, 2022 | |
Stockholders' Deficit (Details) [Line Items] | ||
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock issued | 0 | 0 |
Preferred stock outstanding | 0 | 0 |
Common Class A [Member] | ||
Stockholders' Deficit (Details) [Line Items] | ||
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock shares outstanding | 3,329,638 | 5,076,777 |
Common stock shares subject to possible redemption | 3,329,638 | 5,076,777 |
Common stock shares outstanding | 3,329,638 | 5,076,777 |
Common Class B [Member] | ||
Stockholders' Deficit (Details) [Line Items] | ||
Common stock, shares authorized | 10,000,000 | 10,000,000 |
Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock shares outstanding | 5,750,000 | 5,750,000 |
Conversion rate percentage of common stock outstanding | 20% |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Fair Value Measurements (Details) [Line Items] | |||||
Benefit/(charge) resulting from a decrease/(increase) in fair value of erivative warrant liabilities | $ (188,500) | $ (2,827,500) | $ 377,000 | $ (9,875,500) | |
Fair Value, Recurring [Member] | |||||
Fair Value Measurements (Details) [Line Items] | |||||
Assets, fair value disclosure | $ 0 | 0 | $ 0 | ||
Public Warrants [Member] | |||||
Fair Value Measurements (Details) [Line Items] | |||||
Benefit/(charge) resulting from a decrease/(increase) in fair value of erivative warrant liabilities | $ (400,000) | $ 10,300,000 |
Fair Value Measurements (Deta_2
Fair Value Measurements (Details) - Schedule of fair value on a recurring basis - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
Fair Value, Inputs, Level 1 [Member] | ||
Liabilities: | ||
Derivative warrant liabilities – Public | $ 0 | $ 805,000 |
Derivative warrant liabilities – Private Placement | 0 | 0 |
Fair Value, Inputs, Level 2 [Member] | ||
Liabilities: | ||
Derivative warrant liabilities – Public | 1,035,000 | 0 |
Derivative warrant liabilities – Private Placement | 661,500 | 514,500 |
Fair Value, Inputs, Level 3 [Member] | ||
Liabilities: | ||
Derivative warrant liabilities – Public | 0 | 0 |
Derivative warrant liabilities – Private Placement | $ 0 | $ 0 |
Fair Value Measurements (Deta_3
Fair Value Measurements (Details) - Schedule of derivative warrant liabilities - USD ($) | 3 Months Ended | |
Jun. 30, 2022 | Mar. 31, 2022 | |
Subsidiary, Sale of Stock [Line Items] | ||
Derivative warrant liabilities at begining | $ 1,764,000 | $ 4,557,000 |
Change in fair value of derivative warrant liabilities | (1,102,500) | (2,793,000) |
Transfer of Public Warrants to Level 1 | 0 | |
Derivative warrant liabilities at ending | $ 661,500 | $ 1,764,000 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) | Jul. 31, 2023 | Jun. 26, 2023 | Dec. 08, 2022 | Dec. 02, 2022 | Jun. 30, 2023 | Dec. 31, 2022 |
Subsequent Event [Line Items] | ||||||
Assets held in trust noncurrent | $ 53,637,523 | $ 52,128,420 | ||||
Common Class A [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Temperory equity shares during the period shares | 1,747,139 | 17,923,223 | 17,923,223 | |||
Temporary equity common stock possible to redemption shares | 3,329,638 | 5,076,777 | 3,329,638 | 5,076,777 | ||
Assets held in trust noncurrent | $ 36,900,000 | $ 52,100,000 | ||||
Subsequent Event [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Temperory equity shares during the period shares | 1,747,139 | |||||
Temporary equity common stock possible to redemption shares | 3,329,638 | |||||
Assets held in trust noncurrent | $ 36,900,000 | |||||
Subsequent Event [Member] | Common Class A [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Amount paid to Stockholders | $ 18,432,316 |